UK M&A deals of the week: 25 July 2025

UK M&A deals of the week: 25 July 2025

Five major UK deals defined this M&A-heavy week. Cross-border buyers dominated activity, UK corporates stepped up, and private equity returned to London listings with cash in hand.








This week’s transactions reflect a sharpened dual narrative in UK dealmaking: foreign capital remains attracted to discounted London listings, while UK corporates are confidently executing strategic acquisitions abroad. The Corpay–Alpha deal underscores how international buyers continue to view UK-listed fintechs as undervalued relative to fundamentals, while Compass’s €1.5bn move for Vermaat illustrates outbound ambition among balance-sheet-strong UK firms.

Private equity also reasserted its presence, with Apax and Ares’ take-private of Apax Global Alpha reinforcing the structural challenge facing listed investment trusts trading below NAV. As discounts persist across the LSE, more vehicles may face similar outcomes, especially with secondaries capital seeking discounted exposure and quicker returns.

Elsewhere, regulatory and macro pressures remain material. Close Brothers’ divestiture of Winterflood was driven not by strategy but necessity — a reminder that UK financials remain in balance sheet triage mode following legacy redress liabilities. Meanwhile, in the SaaS space, AI remains a defining strategic edge. The Accelo–Forecast tie-up is emblematic of a consolidating mid-market where predictive technology is increasingly a prerequisite for acquisition.

While few deals crossed the £2bn mark, the market continues to signal steady mid-market momentum. Cross-border strategic logic, regulatory pragmatism, and the persistence of valuation arbitrage remain the principal drivers as we head into August.

  • Cross-border flows continue in both directions: US-based Corpay targeted a UK fintech, while Compass made its largest-ever acquisition in Europe — reinforcing the global nature of UK-linked M&A.
  • Listed discounts remain in play: Apax Global Alpha’s take-private shows persistent NAV gaps continue to attract PE interest in London-listed vehicles.
  • Strategics are active amid sector-specific logic: From Marex’s UK cash equities push to Accelo’s AI scheduling focus, acquirers are targeting capabilities that offer defensible edge or diversification.
  • Regulatory and reputational factors drive asset sales: Close Brothers’ Winterflood divestment highlights how non-core disposals are being used to shore up capital in the wake of regulatory overhangs.

Stay ahead of the curve with Business Quarter’s weekly M&A briefing, a concise, authoritative roundup of the biggest deals, strategic plays, and market-moving partnerships.

Sign up now to get each week’s summary straight to your inbox.

← Back

Thank you for your response. ✨

—



  • Northern Ireland backs £11.7m pharma innovation push

    Northern Ireland backs £11.7m pharma innovation push

    Northern Ireland is backing pharmaceutical innovation with £11.7m investment funding. Queen’s University Belfast and Ulster University will deliver iPHARMA, giving businesses access to specialist facilities and expertise intended to accelerate product development and commercialisation.


  • Amazon signs Shetland wind power agreement

    Amazon signs Shetland wind power agreement

    Amazon expanded its UK renewable portfolio with Shetland wind power. A new agreement with Statkraft covers 36MW from the planned Mossy Hill wind farm near Lerwick, which is expected to begin operating in 2030.


  • eEnergy seeks £4m as AIM trading pauses

    eEnergy seeks £4m as AIM trading pauses

    eEnergy is seeking fresh capital after working-capital pressures intensified sharply. The AIM-listed energy-services group wants at least £4m after delayed receipts affected supplier payments and installations, prompting a temporary suspension in share trading.